Description
Tirzepatide is a novel dual GIP and GLP-1 receptor agonist. It represents a breakthrough in metabolic health research, showing promise in weight management and glucose regulation studies.
Price range: $125.00 through $200.00
Dual GIP/GLP-1 receptor agonist for metabolic research
Tirzepatide is a novel dual GIP and GLP-1 receptor agonist. It represents a breakthrough in metabolic health research, showing promise in weight management and glucose regulation studies.
Reviews
There are no reviews yet.